Comparison of outcome measures during treatment with the proprietary Harpagophytum extract Doloteffin® in patients with pain in the lower back, knee or hip

Phytomedicine

Volumn 9, Issue 3, 2002, Pages 181-194

  Chrubasik, S ^a,b   Thanner, J ^a   Kunzel O ^a   Conradt, C ^c   Black, A ^d   Pollak, S ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Harpagophytum; Hip; Knee; Low back; Outcome measures; Pain

Indexed keywords

DOLOTEFFIN; HARPAGOPHYTUM EXTRACT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE; AGED; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; COXITIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FUNCTIONAL ASSESSMENT; HIP DISEASE; HUMAN; INTERMETHOD COMPARISON; KNEE DISEASE; KNEE OSTEOARTHRITIS; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PAIN ASSESSMENT; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

HARPAGOPHYTUM;

EID: 0036250037     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1078/0944-7113-00140     Document Type: Article

References (42)

1. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee
2. The American College of Rheumatology criteria for classification and reporting of osteoarthritis of the hip
3. Treatment outcome of chronic non-malignant pain patients managed in a Danish multidisciplinary pain centre compared to general practice: A randomised controlled trial
4. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip and knee
5. A comparison of observational studies and randomized controlled trials
6. Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgery
7. Generic and condition-specific outcome measures for people with osteoarthritis of the knee
8. Efficacy and tolerability of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis
9. Effectiveness of Harpagophytum procumbens in treatement of acute low back pain
10. Wirksamkeit und Wirtschaftlichkeit von teufelskrallenwurzelextrakt bei rückenschmerzen: Erste ergebnisse einer anwendungsbeobachtung
11. A survey on pain complaints and health care utilization in a German population sample
12. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: A randomized placebo-controlled double-blind study
13. Treatment of low back pain exacerbations with willow bark extrakt: A randomised double-blind study
14. Potential economic impact of using a proprietary willow bark extract in outpatient treatment of low back pain: An open non-randomized study
15. Treating low back pain with an extract of Harpagophytum procumbens that inhibits cytokine release
16. Doloteffin versus Vioxx for low back pain - A randomized double-blind study
17. Treatment of low back pain with a herbal or synthetic antirheumatic: A randomized controlled study
18. The management of chronic pain in older persons
19. Descriptive epidemiology of low back pain and its related medical care in the United States
20. A comparison of pain, functional limitations, and work status indices as outcome measures in back pain research
21. The assessment of disability: From first to future principles
22. A placebo-controlled study of diclofenac sodium for the treatment of osteoarthritis of the hip and knee
23. Harpagophytum-extrakt LI174 (teufelskralle) bei der behandlung unspezifischer rückenschmerzen
24. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly patients
25. Multidisciplinary rehabilitation for chronic low back pain: Systematic review
26. Guidelines for the medical management of steoarthritis. Parts 1 and 2
27. A study of the Health Assessment Questionnaire to evaluate functional status in polymyalgia rheumatica
28. Vergleichende evaluation einer deutschen version des health assessment questionnaires (HAQ) und des funktionsfragebogens Hannover (FFbH)
29. Epidemiology and pharmacoeconomic implications of non-steroidal anti-inflammatory drug-associated gastrointestinal toxicity
30. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies
31. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip
32. Low back rating scale: Validation of a tool for assessment of low back pain
33. The therpeutic approaches of community based primary care practitioners to osteoarthritis of the hip in an elderly patient
34. Comparative responsiveness of measures of pain and function after total hip replacement
35. Consumption of NSAIDs and the development of congestive heart failure in elderly patients
36. Preference for nonsteroidal anti-inflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis
37. Epidemiology of rheumatic diseases
38. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly patients
39. Evaluation einer deutschen version des WOMAC (Western Ontario und McMaster Universities) arthroseindex
40. Conservative treatment of acute and chronic nonspecific low back pain
41. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients